BriaCell Therapeutics Corp. (NASDAQ:BCTXW) Sees Large Decrease in Short Interest

BriaCell Therapeutics Corp. (NASDAQ:BCTXW) was the recipient of a significant drop in short interest in the month of July. As of July 31st, there was short interest totalling 200 shares, a drop of 88.2% from the July 15th total of 1,700 shares. Based on an average daily volume of 116,400 shares, the short-interest ratio is presently 0.0 days.

BriaCell Therapeutics Stock Down 0.3 %

Shares of NASDAQ BCTXW traded down $0.00 during midday trading on Monday, hitting $0.18. The company had a trading volume of 131,578 shares, compared to its average volume of 64,912. BriaCell Therapeutics has a twelve month low of $0.11 and a twelve month high of $3.30. The business has a 50-day simple moving average of $0.26 and a two-hundred day simple moving average of $0.87.

About BriaCell Therapeutics

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers.